1	13 Subjects taking inducers of LTG glucuronidation i.e. rifampicinor lopinavir/ritonavir atazanavir/ritonavir risperidone or oral contraceptives or hormone drugs containing estrogen|risperidone[110,121]|||||||||C0073393|35636|35636|risperidone
1	13 Subjects taking inducers of LTG glucuronidation i.e. rifampicinor lopinavir/ritonavir atazanavir/ritonavir risperidone or oral contraceptives or hormone drugs containing estrogen|atazanavir / ritonavir[89,109]|||||||||null|1601653|1601653|atazanavir / ritonavir
1	13 Subjects taking inducers of LTG glucuronidation i.e. rifampicinor lopinavir/ritonavir atazanavir/ritonavir risperidone or oral contraceptives or hormone drugs containing estrogen|lopinavir / ritonavir[69,88]|||||||||C0939237|284640|284640|lopinavir and ritonavir
1	13 Subjects taking inducers of LTG glucuronidation i.e. rifampicinor lopinavir/ritonavir atazanavir/ritonavir risperidone or oral contraceptives or hormone drugs containing estrogen|oral contraceptives[125,144]||||||||||2821|2821|oral contraceptives
1	13 Subjects taking inducers of LTG glucuronidation i.e. rifampicinor lopinavir/ritonavir atazanavir/ritonavir risperidone or oral contraceptives or hormone drugs containing estrogen|estrogen[173,181]||||||||||4100|4100|estrogens
